Où? Hof ter Musschen, Brussels
During this meeting presentations will be given about the current status of the JACIEprocess in Europe and Belgium, the role of JACIEin accreditation of immune effector cell therapy (CAR-T cells) programmes and risk assessment of procedures and processes in SCT centers.
In addition a round table discussion will be organized to exchange personal experiences and to discuss about specific problems in relation to the JACIEquality system. The target audience includes clinical program directors, nurses, physicians, laboratory and collection facility directors,
laboratory technicians, quality managers, pharmacists, data managers and other staff members that are involved or interested in the JACIEprocess.